Trending

stroke

UK hospital will use MindMaze game to aid stroke recovery

UK hospital will use MindMaze game to aid stroke recovery

A hospital trust has become the first in the UK to deploy a gaming system developed by Swiss

X

UK hospital will use MindMaze game to aid stroke recovery

https://pharmaphorum.com/news/uk-hospital-will-use-mindmaze-game-to-aid-stroke-recovery/

Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS

Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS

Biogen has licensed a new drug from Japanese biotech TMS that it hopes could provide a big advance

X

Biogen bolsters ischaemic stroke pipeline with thrombolytic from TMS

https://pharmaphorum.com/news/biogen-bolsters-ischaemic-stroke-pipeline-with-thrombolytic-from-tms/

Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systems

Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systems

Injected neurotoxins can be incredibly potent in treating spasticity from neurological diseases, but the field doesn’t always get

X

Ipsen’s John Chaddock on making neurotoxins a priority for healthcare systems

https://pharmaphorum.com/r-d/views-analysis-r-d/ipsens-john-chaddock-on-making-neurotoxins-a-priority-for-healthcare-systems/

Chasing Brilinta payoff, AZ details THALES data in ischemic stroke

Chasing Brilinta payoff, AZ details THALES data in ischemic stroke

AstraZeneca has lifted the veil on the large-scale THALES trial of its antiplatelet drug Brilinta in stroke, the

X

Chasing Brilinta payoff, AZ details THALES data in ischemic stroke

https://pharmaphorum.com/news/chasing-brilinta-payoff-az-details-thales-data-in-ischemic-stroke/

FDA grants fast review of AZ’s Brilinta to prevent recurring strokes

FDA grants fast review of AZ’s Brilinta to prevent recurring strokes

The FDA has granted a fast review of AstraZeneca’s cardiovascular diseases drug Brilinta (ticagrelor) in the new indication that aims to reduce

X

FDA grants fast review of AZ’s Brilinta to prevent recurring strokes

https://pharmaphorum.com/news/az-grants-fast-review-of-astrazenecas-cardiovascular-diseases-drug-brilinta/

Tysabri failure in stroke a setback for Biogen

Tysabri failure in stroke a setback for Biogen

Biogen’s hopes that one of its established multiple sclerosis drugs might also help stroke sufferers have been dashed.

X

Tysabri failure in stroke a setback for Biogen

https://pharmaphorum.com/news/tysabri-failure-stroke-setback-biogen/

The future of stroke treatment

The future of stroke treatment

Stroke is a major cause of disability and death worldwide and the third most common cause of death in developed countries. Nearly six million people die from stroke every year and another five million are left permanently disabled.

X

The future of stroke treatment

https://pharmaphorum.com/views-and-analysis/future-stroke-treatment/

Stroke prevention device wins healthtech award

Stroke prevention device wins healthtech award

Neuravi’s Embotrap II can clear blood clots responsible for stroke.

X

Stroke prevention device wins healthtech award

https://pharmaphorum.com/news/neuravi-digital-health-award/

Virtual reality stroke rehab platform gets FDA clearance

Virtual reality stroke rehab platform gets FDA clearance

MindMotion Pro helps with upper-limb rehabilitation following a stroke.

X

Virtual reality stroke rehab platform gets FDA clearance

https://pharmaphorum.com/news/vr-stroke-rehab-fda-clearance/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com